Agree to a point Eyeman...The team are having a go at the Covid screening tool prize and shouldn't be too far off having some news re their progress soon. They haven't forgotten their core business that is the point really. The RAPid Covid Cough Test is taking some resources in terms of time, money and perhaps some personnel (most likely mainly consultants). Lets not forget the advantages in the event they fail to achieve >80% successful diagnosis...the advantage will be a stack more valuable data and lessons in learning more about the algorithm. On the other hand if they achieve their aims we all agree it should be a huge winner both in prestige, reputation, market/public/international awareness and of course the SP. Lets not forget the SP. No need to rub it in tht in a moment of clarity you got out at the 14 cents...bully for you however to complete your mastery you maybe should have bought back in at the low 4 cent mark and pulled a double and got out again for around 9 cents. It doesn't matter as some choose to hold and wait. As yet they haven't "sought" FDA approval for the algorithm for Covid they are getting advice on the best way forward with the application at this stage. I suggest that you are correct in that RAP have a significant product but I disagree when you say they don't or aren't bringing this product to market...they in fact are doing this...read the last 6 months announcements...they are getting many big name companies onboard now in increasing frequency. The way these companies describe RAP's tech then there is little doubt it is genius stuff and little doubt re where the company is going. Slowly catchee monkey...in this case very slowly but it is speeding up now. Significant product and is being brought to market...blind Freddy can see that Eyeman. Having a mighty crack at Covid is not just a frivolous sideline...it is a company maker perhaps...soon we shall see just how it is all going. By all reports the Rap team couldn't be more pleased...they don't shoot from the hip...TK is too conservative for that. You must be getting itchy to buy back in by now...after all you sold at double the SP it is now.
- Forums
- ASX - By Stock
- RAP
- Ann: Health Teams to launch ResAppDx on aged care platform
Ann: Health Teams to launch ResAppDx on aged care platform, page-36
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online